• FULL-TEXT PDF ARTICLE
  The role of harm reduction in controlling HIV among injecting drug users
  Wodak A, McLeod L  AIDS Aug 2008
   

• Accessing care for injection-related infections through a medically supervised injecting facility:
  A qualitative study.
  Small W, Wood E, Lloyd-Smith E, et al Drug Alcohol Depend. 2008 Jul 21.
• Estimating the size and dynamics of an injecting drug user population and implications for health service coverage:
  comparison of indirect prevalence estimation methods.
  Kimber J, Hickman M, Degenhardt L, et al  Addiction. 2008 Jul 14.
• Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
  Lawrinson P, Ali R, Buavirat A, et al  Addiction. 2008 Jul 10.
• Public injecting among a cohort of injection drug users in Vancouver, Canada.
  Debeck K, Small W, Wood E, et al   J Epidemiol Community Health. 2008 Jul 15.
• Drug use and risk among regular injecting drug users in Australia: does age make a difference?
  Degenhardt L, Kinner SA, Roxburgh A, et al  Drug Alcohol Rev. 2008 Jul;27(4):357-60
• Mechanism of Ritonavir Changes in Methadone Pharmacokinetics and Pharmacodynamics:
  II. Ritonavir Effects on CYP3A and P-Glycoprotein Activities.
  Kharasch E, Bedynek P, Walker A, Whittington D, Hoffer C.  Clin Pharmacol Ther. 2008 Jul 9.
• Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates
  in adherent patients.
  Bruggmann P, Falcato L, Dober S,et al J Viral Hepat. 2008 Jul 10.
• HIV transmission as a result of drug market violence: a case report.
  Small W, Kerr T, Wood E.  Confl Health. 2008 Jul 18;2(1):8.
• FULL TEXT PDF ARTICLE
  Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection
  drug users at a referral hospital.
  Liang SH, Lo YC, Lin HH, et al J  Microbiol Immunol Infect. 2008 Jun;41(3):200-8.
• Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment
  programs: a national drug abuse treatment clinical trials network study.
  Wu LT, Blazer DG, Stitzer ML, et al   Am J Addict. 2008 Jul-Aug;17(4):304-11.
• Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers.
  Walley AY, Alperen JK, Cheng DM, et al J Gen Intern Med. 2008 Jul 1.
• A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.
  Kinlock TW, Gordon MS, Schwartz RP, O'Grady KE.,et al  Crim Justice Behav. 2008;35(1):34-47.
• Prevalence and correlates of jugular injections among injection drug users.
  Hoda Z, Kerr T, Li K, et al  Drug Alcohol Rev. 2008 Jul;27(4):442-6.
• A WEEK IN REVIEW FEATURED REPORT
• The Fine Line between Harm Reduction and Harm Production - Development of a Clinical Policy on
  Femoral (Groin) Injecting.
  Zador D, Lintzeris N, van der Waal R, er al  Eur Addict Res. 2008 Jun 27;14(4):213-218.
• A review of barriers and facilitators of HIV treatment among injection drug users.
  Wood E, Kerr T, Tyndall MW, Montaner JS.AIDS. 2008 Jul 11;22(11):1247-56.
• A WEEK IN REVIEW FEATURED REPORT
  Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration
  with fosamprenavir-ritonavir in opioid-dependent subjects.
  Cao YJ, Smith PF, Wire MB, Lou Y, et al  Pharmacotherapy. 2008 Jul;28(7):863-74.
• Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.
  Milloy MJ, Kerr T, Mathias R,et al   Am J Drug Alcohol Abuse. 2008;34(4):499-509.
• Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency
  virus risk behaviors.
  Sullivan LE, Moore BA, Chawarski MC, et al  J Subst Abuse Treat. 2008 Jul;35(1):87-92.
• Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.
  Willner-Reid J, Belendiuk KA, Epstein DH, et al  J Subst Abuse Treat. 2008 Jul;35(1):78-86.
• Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal
  outcomes in two consecutive case series.
  Kakko J, Heilig M, Sarman I.  Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78
• Contingency management reduces drug-related human immunodeficiency virus risk behaviors in
  cocaine-abusing methadone patients.
  Hanson T, Alessi SM, Petry NM.  Addiction. 2008 Jul;103(7):1187-97.
• Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
  Winstock AR, Lea T, Sheridan J.  Drug Alcohol Rev. 2008 Jul;27(4):393-7.
   

          Conference Reports, Abstracts, and Posters

FULL-TEXT ARTICLE
Injection Drug Use Quality of Life scale (IDUQOL): A validation study.
Hubley AM, Russell LB, Palepu A.  
Health Qual Life Outcomes. 2005 Jul 19;3(1):43
Paper